Overall DRUG gets a technical rating of 10 out of 10. This is due to a consistent performance in both the short and longer term time frames. Also compared to the overall market, DRUG is showing a nice and steady performance.
Although DRUG has an excellent technical rating, it does not present a decent entry opportunity at the moment. Price movement has been a little bit too volatile to find a nice entry and exit point. It is probably a good idea to wait for a consolidation first.
More info and screens
50.32
3 important support areas can be observed.
- Support @65.13 from a trend line in the daily time frame.
- Support @60.49 from a trend line in the daily time frame.
- Support @50.83 from a horizontal line in the daily time frame.
The Technical Rating and Setup analysis above combine different indicators and trends in different timeframes. Individual signals from indicators may give more contradictive signals and should always be interpreted in the more global context.
| Indicator | Value | Signal | Comment |
|---|---|---|---|
| ChartMill Long Term Trend Indicator | UP | POSITIVE | The long term trend for DRUG is up. |
| ChartMill Short Term Trend Indicator | UP | POSITIVE | The short term trend for DRUG is up. |
| ChartMill Relative Strength | 96.55 | POSITIVE | DRUG has a high relative strength, it outperformed 96.55% off all stocks on the market. |
| Simple Moving Average/SMA (20) | UP | POSITIVE | The current price of DRUG is above the rising SMA(20). |
| Simple Moving Average/SMA (50) | UP | POSITIVE | The current price of DRUG is above the rising SMA(50). |
| Simple Moving Average/SMA (200) | UP | POSITIVE | The current price of DRUG is above the rising SMA(200). |
| Relative Strength Index/RSI (14) | 69.31 | NEUTRAL | The RSI value for DRUG is a neutral value. |
| Moving Average Convergence Divergence/MACD (12, 26, 9) | 1.76 | POSITIVE | The MACD value suggests DRUG has a positive trend, although the MACD value is declining. |
| Stochastics (14,3) | 83.72 | OVERBOUGHT | The high Stochastics value suggests DRUG may be overbought. |
| Average True Range in percent/ATR (20) | 7.02 | HIGH VOLATILITY | The high ATR as a percentage value for DRUG suggests high volalility. |
| Average Directional Index/ADX (14) | 43.16 | POSITIVE | The high ADX value value for DRUG suggests a strong trend. |
NASDAQ:DRUG (12/12/2025, 8:25:54 PM)
84.19
-4.82 (-5.42%)
BRIGHT MINDS BIOSCIENCES INC / DRUG FAQ
What is the ChartMill technical rating of BRIGHT MINDS BIOSCIENCES INC (DRUG) stock?
ChartMill assigns a technical rating of 10 / 10 to DRUG.
What is the trend direction for DRUG stock?
The current trend direction for BRIGHT MINDS BIOSCIENCES INC (DRUG) is Bullish.
What is the RSI signal for BRIGHT MINDS BIOSCIENCES INC (DRUG) stock?
BRIGHT MINDS BIOSCIENCES INC (DRUG) has an RSI value of 69.3101. This indicates that the stock is currently neutral.
Can you provide the buy/sell signal for BRIGHT MINDS BIOSCIENCES INC?
The buy/sell signal for BRIGHT MINDS BIOSCIENCES INC (DRUG) is buy as both the short term and long term trends are positive.
What are the support and resistance levels for BRIGHT MINDS BIOSCIENCES INC (DRUG) stock?
BRIGHT MINDS BIOSCIENCES INC (DRUG) has a support level at 65.13. Check the full technical report for our detailed analysis of DRUG support and resistance levels.